We will rely on you to help lend your voice and support the biotechnology industry.
Learn more about BIO initiatives to advance the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO CEO & Investor Conference
February 12-13, 2018
BIO IP Counsels Committee Conference
April 11-13, 2018
BIO Industry Analysis Reports
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
July 16 - 19, 2018 | Philadelphia, Pennsylvania
Dr. Patrick Gruber is the Chief Executive Officer of Gevo and has served as a director of the company since 2007. Previously, he was the President and Chief Executive Officer of Outlast Technologies Inc., a technology and marketing company primarily serving the textile industry. In 1997, Dr. Gruber co-founded NatureWorks, LLC (formerly Cargill Dow, LLC), and served as Vice President of Technology and Operations and Chief Technology Officer until 2005.
Dr. Gruber is an advisor to the Energy Future Coalition. He currently serves on the boards of directors of Gevo and Segetis.
In 2008, Dr. Gruber was awarded the first ever George Washington Carver Award. The award recognizes significant contributions by individuals in the field of industrial biotechnology and its application in biological engineering, environmental science, biorefining and biobased products.
As an extraordinary visionary, a revolutionary scientist, and a transformational leader, Dr. Gruber received an Outstanding Achievement Award from the University of Minnesota in 2011. This award recognized Dr. Gruber’s work in the development and commercialization of green chemical production processes, his contributions to industrial biotechnology, and his ability to identify and act on business opportunities.
Dr. Gruber holds an M.B.A. from the University of Minnesota, Carlson School of Management, a Ph.D. in chemistry from the University of Minnesota and a B.S. in chemistry and biology from the University of St. Thomas.
This speaker's sessions: